SAN DIEGO--(BUSINESS WIRE)--XIFIN Inc., the company revolutionizing revenue cycle management for diagnostic service providers, announced today that American International Biotechnology Services, LLC (AI BioTech) a leading clinical research organization in Richmond, VA, has selected XIFIN’s revenue cycle management system to optimize billing and claims management and provide technological guidance in support of the rapidly changing molecular diagnostics landscape.